The drug Lecanemab authorized on the American market
The molecule Lecanemab, or Leqembi, developed by the Eisai laboratory in partnership with Biogen, has been placed on the American market by the Food and Drug Organization (FDA). The two pharmaceutical giants had presented, in September, highly significant results, with a 27% reduction in cognitive decline in people affected by Alzheimer’s disease at a mild …
The drug Lecanemab authorized on the American market Read More »